Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886907 · ClinicalTrials.gov registry record · NA
Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
A NA study of Presbyopia and Astigmatism, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT05886907: Completed NA study of Presbyopia and Astigmatism, sponsored by Alcon Research.
NCT05886907 is a NA study of Presbyopia and Astigmatism that has completed, run by Alcon Research. The registered enrollment target is 18 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05886907, a NA study of Presbyopia and Astigmatism, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to assess on-eye performance and overall fit of an investigational multifocal toric contact lens to aid in confirmation of the study lens design.
Primary Outcome
Visual Acuity (VA) was assessed binocularly (both eyes together) with study lenses in place at a distance of 4 meters using letter charts. VA was recorded in logarithm minimum angle of resolution (logMAR), where 0.0 logMAR equates to 20/20 Snellen (normal distance eyesight). A lower number indicates better visual acuity. No hypothesis testing is pre-specified for this endpoint.
Conditions Studied
Interventions
- DEVICE CLEAR CARE
- DEVICE Lehfilcon A multifocal toric contact lenses
- DEVICE Samfilcon A multifocal toric contact lenses
Study Locations (1)
Georgia
- Johns Creek Research Clinic - Johns Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2023-07-17 |
| Phase | NA |
What the finished NCT05886907 record still lists
NCT05886907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Presbyopia appearing as the primary indexed condition, and to 3 interventions - of which CLEAR CARE is the first listed.
NCT05886907 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05886907 about?
NCT05886907 is a clinical study titled "Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses". The purpose of this clinical trial is to assess on-eye performance and overall fit of an investigational multifocal toric contact lens to aid in confirmation of the study lens design.
What is the current status of trial NCT05886907?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-06-14. Estimated completion is 2023-07-17.
What conditions does trial NCT05886907 study?
This clinical trial studies the following conditions: Presbyopia, Astigmatism, Refractive Errors.
What interventions are being tested in trial NCT05886907?
The interventions under investigation include: CLEAR CARE (DEVICE), Lehfilcon A multifocal toric contact lenses (DEVICE), Samfilcon A multifocal toric contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05886907?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05886907 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05886907's enrollment target sits among peer trials
18 37th of 38 higher than 2 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI